YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.
Aká je dnes cena akcie spoločnosti YiChang HEC ChangJiang Pharmaceutical?▼
Aktuálna cena akcie 1558.HK je HK$15,88 HKD — za posledných 24 hodín klesla o -0,5%. Vývoj ceny akcie spoločnosti YiChang HEC ChangJiang Pharmaceutical môžete podrobnejšie sledovať v grafe.
Aký ticker má akcia spoločnosti YiChang HEC ChangJiang Pharmaceutical?▼
Ticker akcie sa môže líšiť podľa burzy. Napríklad na burze Hong Kong Exchange sa akcie spoločnosti YiChang HEC ChangJiang Pharmaceutical obchodujú pod tickerom 1558.HK.
Aké boli tržby spoločnosti YiChang HEC ChangJiang Pharmaceutical za minulý rok?▼
Tržby spoločnosti YiChang HEC ChangJiang Pharmaceutical za posledný rok predstavujú 3,99B HKD.
Aký je čistý zisk spoločnosti YiChang HEC ChangJiang Pharmaceutical za minulý rok?▼
Čistý zisk 1558.HK za posledný rok predstavuje 520,74M HKD.